Bisola Hamzat
Biographic Data
| ID | 5410693 |
|---|---|
| NAME | Bisola Hamzat |
| GIVEN NAMES | Bisola |
| FAMILY NAME | Hamzat |
| SIGNATURE | HAMZAT B |
| AFFILIATIONS | St. Michael's Hospital |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Safer opioid supply initiation among First Nations Peoples in Ontario, Canada, 2019 to 2023
Overall, the rate of First Nations Peoples accessing SOS in Ontario increased almost five-fold, demonstrating growing engagement with this harm reduction approach. Future research is needed to understand First Nations People's experiences with SOS, and the impacts of program closures across Canada
Assessing the impact of the introduction of generic methadone to the Ontario public drug formulary
Our findings did not indicate broad treatment destabilization or increased opioid-related toxicity among methadone recipients in the months following the introduction of generic products. Early notification of formulary changes, phased implementation of the policy, as well as information resources developed for patients and clinicians may have played a role in mitigating potential disruptions for this population
Trends in the dispensing of opioids for pain and concurrent benzodiazepine use among First Nations People in Ontario, Canada, from 2013 to 2021
Opioid analgesic prescribing patterns for First Nations People living in Ontario indicate a decrease in both overall prescribing rates and concurrent benzodiazepine use
No prominent works on this page.
Assessing the impact of the introduction of generic methadone to the Ontario public drug formulary
Our findings did not indicate broad treatment destabilization or increased opioid-related toxicity among methadone recipients in the months following the introduction of generic products. Early notification of formulary changes, phased implementation of the policy, as well as information resources developed for patients and clinicians may have played a role in mitigating potential disruptions for this population
Trends in the dispensing of opioids for pain and concurrent benzodiazepine use among First Nations People in Ontario, Canada, from 2013 to 2021
Opioid analgesic prescribing patterns for First Nations People living in Ontario indicate a decrease in both overall prescribing rates and concurrent benzodiazepine use
Safer opioid supply initiation among First Nations Peoples in Ontario, Canada, 2019 to 2023
Overall, the rate of First Nations Peoples accessing SOS in Ontario increased almost five-fold, demonstrating growing engagement with this harm reduction approach. Future research is needed to understand First Nations People's experiences with SOS, and the impacts of program closures across Canada
Opioid (3 works) · Opioid Use Disorder Treatment (3 works) · Environmental health (2 works) · HIV, Drug Use, Sexual Risk (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Population (2 works) · Anesthesia (1 works) · Benzodiazepine (1 works) · Cross-sectional study (1 works)